The size of the Latin America Injectable Drug Delivery Market was valued at USD 5972.87 million in 2022. It is further estimated to be growing at a CAGR of 11.32%, to reach USD 10210.56 million by 2027.
One of the major factors driving the injectable drug delivery market in the Latin American region is that healthcare infrastructure in Brazil, Mexico, and Argentina has vastly improved in recent years. These countries are also thought to have strong growth potential. These countries' vast populations are in desperate need of specialized medicine delivery technologies. This is a powerful incentive for government officials and local pharmaceutical businesses to work toward the widespread adoption of these systems.
The increased need for vaccinations, insulin, human growth hormone, and many other modern medicines used to treat cancer and other chronic conditions is another significant factor contributing to the market's growth. Furthermore, because biologics are mostly provided via injection, the injectable medication delivery and prefilled syringe markets are projected to experience significant growth in the future years. In addition, the growing demand for biosimilar and generic injectables, quick technological breakthroughs and new product releases, and strong growth in the biologics industry are expected to provide considerable growth possibilities.
However, there have been multiple products recalls in the injectable medicine delivery technology sector in recent years. Recalls can happen on their own or as a result of regulatory involvement. Injectables have also been recalled due to contamination from inorganic materials such as glass, silicone, stainless steel, and improper vial filling. During the development phase, usability issues must be discovered and solved. The presence of visible foreign matter during retention sample testing in injectables might have serious health repercussions, including permanent impairment of a body function, blood vessel injury, and obstruction. If a product is recalled, the process of collecting and replacing the defective goods can result in significant losses for a firm or manufacturer. These massive losses will influence the company's revenue and market share, which will have an impact on the broader market.
This research report on the Latin America Injectable Drug Delivery Market has been segmented and sub-segmented into the following categories:
By Device Type:
By Formulation:
By Therapeutic use:
By End User:
By Country:
Due to the widespread acceptance of sophisticated injectable medicine delivery and the growing patient population, the Latin American market is expected to register a promising share in the global market during the forecast period.
In Latin America, the Brazilian market is predicted to dominate during the forecast period, whereas Mexico and Argentina are estimated to register healthy growth rates.
KEY MARKET PLAYERS:
A few of the noteworthy companies operating in Latin America Injectable drug delivery market profiled in the report is Antares Pharmaceuticals Ltd, Baxter International, Becton Dickinson Company, Elcam Medical, Eli Lily and Company, Unilife Corporation, and West Pharmaceutical Inc.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Device Type
5.1.1 Introduction
5.1.2 Self-injection Devices
5.1.3 Conventional Devices
5.1.4 Y-o-Y Growth Analysis, By Device Type
5.1.5 Market Attractiveness Analysis, By Device Type
5.1.6 Market Share Analysis, By Device Type
5.2 Formulation
5.2.1 Introduction
5.2.2 Conventional Drug Delivery
5.2.3 Novel Drug Delivery
5.2.4 Y-o-Y Growth Analysis, By Formulation
5.2.5 Market Attractiveness Analysis, By Formulation
5.2.6 Market Share Analysis, By Formulation
5.3 Therapeutic Use
5.3.1 Introduction
5.3.2 Autoimmune Disorders
5.3.3 Hormonal Disorders
5.3.4 Oncology
5.3.5 Y-o-Y Growth Analysis, By Therapeutic Use
5.3.6 Market Attractiveness Analysis, By Therapeutic Use
5.3.7 Market Share Analysis, By Therapeutic Use
5.4 End-user
5.4.1 Introduction
5.4.2 Hospitals
5.4.3 Homecare Settings
5.4.4 Research Institutes
5.4.5 Clinical Laboratories
5.4.6 Other
5.4.7 Y-o-Y Growth Analysis, By End-user
5.4.8 Market Attractiveness Analysis, By End-user
5.4.9 Market Share Analysis, By End-user
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Device Type
6.1.3.3 By Formulation
6.1.3.4 By Therapeutic Use
6.1.3.5 By End-user
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Device Type
6.1.4.3 By Formulation
6.1.4.4 By Therapeutic Use
6.1.4.5 By End-user
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Device Type
6.1.5.3 By Formulation
6.1.5.4 By Therapeutic Use
6.1.5.5 By End-user
6.2 Brazil
6.3 Mexico
6.4 Rest of Latin America
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Alkermes Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Bend Research
8.3 BIND Biosciences Inc.
8.4 Endocyte
8.5 Genentech Inc.
8.6 MicroCHIPS Inc.
8.7 Pearl Therapeutics Inc.
8.8 Polymer Factory
8.9 Presage Bioscience
8.10 QLT Inc.
8.11 UCB Group.
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.